- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05155111
Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy
Telemedicine for Identification of Neonatal Encephalopathy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Neonatal encephalopathy is a clinically defined condition of disturbed neurological function in an infant of greater than 35 weeks gestation. Neonatal encephalopathy is most likely to occur following a traumatic birth that requires some degree of neonatal resuscitation. Therapeutic hypothermia (TH) is the standard-of-care neuroprotective therapy employed for neonates who have symptoms of moderate to severe neonatal encephalopathy. Assessment of neonatal encephalopathy can be challenging because the symptoms can fluctuate and because there is time pressure to decide to initiate TH before the neonate is 6 hours old, after which TH has almost no beneficial effect. Doctors struggle with the decision to treat neonates with milder symptoms and these neonates are at risk for two possible adverse outcomes; 1) an eligible neonate is not recognized and therefore not treated with TH or 2) an ineligible neonate may receive unnecessary treatment. The first error is one that can result in lifelong impairments such as learning delays, epilepsy and cerebral palsy for the untreated child and the second error, of unnecessary treatment is costly, invasive and not without risk of associated issues with morphine exposure, cold-induced injury to the skin or complications from venous access such as infection or blood clot.
In Maine, the investigators have successfully implemented telemedicine both in the tertiary care center and in the rural community hospital to permit visual evaluation of neonates and inform joint decision making in these challenging instances. Telemedicine provides the opportunity to have synchronous, unscheduled immediate expert consultation for neonatologists with pediatric neurology in the tertiary care center and for primary care physicians with both specialists in the community hospital setting. The objective of the present study is to develop the telemedicine consultative network to continue to improve patient selection for TH. The investigators aim to use telemedicine consults in three tertiary care centers (Maine Medical Center, Northern Light Eastern Maine Medical Center and the University of Vermont Medical Center) to develop evidence for the threshold at which neonates can be safely excluded from TH treatment. In Aim 1, the investigators will assess neonates with milder symptoms at least twice in the first 6 hours of life and for those not meeting criteria for moderate or severe neonatal encephalopathy, perform electroencephalogram (EEG) to rule out seizures and MRI of the brain to rule out injury. In aim 2, the investigators will compare the interrater reliability between the neonatologist neonatal encephalopathy exam and the one performed via telemedicine by the pediatric neurologist.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alexa K Craig, MD
- Phone Number: 2078831414
- Email: craiga@mmc.org
Study Locations
-
-
Maine
-
Portland, Maine, United States, 04102
- Maine Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Umbilical cord pH ≤7.0 or base deficit ≥ -16
Umbilical cord pH 7.01 to 7.15 or base deficit between -10 and -16 AND one of the following;
- a perinatal event, defined as severe fetal heart rate abnormality such as category 2 or 3 tracing with recurrent variable decelerations, prolonged decelerations or recurrent late decelerations, umbilical cord prolapse/rupture, uterine rupture, significant placental abruption, maternal trauma or hemorrhage or cardiopulmonary arrest)
- 10-minute Apgar score < 5
- Need for respiratory support for >10 minutes not otherwise due to a primary pulmonary process
Exclusion Criteria:
- Older than 6 hours
- Gestational age less than or equal to 35 6/7 weeks
- Birthweight <1800 grams
- Non-English speaking parents due to time constraints to perform the consent process
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telemedicine arm
Neonates will have telemedicine consultation to evaluate symptoms of neonatal encephalopathy
|
A joint assessment between Neonatologist at bedside and Neurologist by telemedicine will be performed to assess severity of neonatal encephalopathy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Combined outcome of seizure or brain Injury on imaging
Time Frame: First 10 days of life
|
The primary outcome is a combined outcome.
This will include the presence of absence of seizure activity on the electroencephalogram (EEG) during the first 24 hours of life and/or the presence or absence of injury to the brain detected on magnetic resonance imaging of the brain (MRI) performed prior to hospital discharge.
|
First 10 days of life
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexa K Craig, MD, Physician
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1781443
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Encephalopathy
-
Children's Hospital of Fudan UniversityNanfang Hospital of Southern Medical University; Guangzhou Women and Children... and other collaboratorsRecruitingNeonatal Encephalopathy | Suspected Neonatal EncephalopathyChina
-
Turku University HospitalNot yet recruitingNeonatal Stroke | Neonatal Hypoxic Ischemic Encephalopathy | Neonatal Encephalopathy, UnspecifiedFinland
-
Imperial College LondonRecruiting
-
The Rotunda HospitalCompletedNeonatal EncephalopathyIreland
-
Neonatal Encephalopathy Consortium, JapanNational Cerebral and Cardiovascular Center; Nagoya University; Tokyo Women's... and other collaboratorsUnknownNeonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)Japan
-
Thayyil, SudhinWayne State UniversityActive, not recruitingNeonatal Encephalopathy | Magnetic Resonance Spectroscopy | Hypothermia NeonatalUnited Kingdom, United States, Italy
-
NYU Langone HealthRecruitingNeonatal EncephalopathyUnited States
-
Thayyil, SudhinUniversity College, London; University of Oxford; University of Manchester; Government... and other collaboratorsActive, not recruitingEpilepsy | Newborn Morbidity | Neonatal EncephalopathyIndia, United Kingdom
-
Imperial College LondonCompletedNeonatal EncephalopathyUnited Kingdom
-
Makerere UniversityUniversity of BergenUnknownNeonatal Encephalopathy | Helping Babies Breathe (HBB) TrainingUganda
Clinical Trials on Telemedicine consult
-
MaineHealthCompletedNeonatal EncephalopathyUnited States
-
University of VermontNeurocrine BiosciencesRecruitingDrug-Induced Movement DisorderUnited States
-
Mayo ClinicUniversity of California, San Diego; Arizona Department of Health Services; Kingman... and other collaboratorsCompletedStroke, AcuteUnited States
-
NYU Langone HealthThe Rainer Arnhold FoundationCompletedCoronary Artery Disease | Hypertension | Obesity | Diabetes | Peripheral Arterial Disease | Hyperlipidemia | PrediabetesUnited States
-
Radboud University Medical CenterUnknown
-
Turtle Health, Inc.WithdrawnFertility RiskUnited States
-
University of VirginiaNamrita OdackalCompletedPremature Birth | Prenatal StressUnited States
-
Centre hospitalier de l'Université de Montréal...Terminated
-
Ottawa Hospital Research InstituteCompletedMortality | Aged | Epidemiology | SURGICAL PROCEDURES, OPERATIVECanada
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Active, not recruitingHeart FailureNetherlands